Complications, symptoms, quality of life and pregnancy in cholestatic liver disease

Kais Zakharia, Anilga Tabibian, Keith Lindor, James H. Tabibian

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Cholestatic liver diseases (CLDs) encompass a variety of disorders of bile formation and/or flow which generally result in progressive hepatobiliary injury and ultimately end-stage liver disease. Many patients with CLD are diagnosed between the ages of 20-50 years, a particularly productive period of life professionally, biologically and in other respects; it is not surprising, thus, that CLD is often associated with impaired health-related quality of life (HRQOL) and uncertainty regarding implications for and outcomes of pregnancy. Primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) are the most prominent CLDs, both having considerable morbidity and mortality and representing major indications for liver transplantation. These disorders, as a consequence of their complications (eg ascites, hepatic osteodystrophy), associated conditions (eg inflammatory bowel disease) and symptoms (eg pruritus and fatigue), can significantly impair an array of domains of HRQOL. Here we review these impactful clinical aspects of PSC and PBC as well as the topics of fertility and pregnancy.

Original languageEnglish (US)
Pages (from-to)399-411
Number of pages13
JournalLiver International
Volume38
Issue number3
DOIs
StatePublished - Mar 1 2018

Fingerprint

Liver Diseases
Quality of Life
Pregnancy
Sclerosing Cholangitis
Cholangitis
End Stage Liver Disease
Pruritus
Pregnancy Outcome
Inflammatory Bowel Diseases
Ascites
Bile
Liver Transplantation
Uncertainty
Fatigue
Fertility
Morbidity
Mortality
Liver
Wounds and Injuries

Keywords

  • biliary tract diseases
  • pharmacotherapy
  • primary biliary cholangitis
  • primary sclerosing cholangitis
  • pruritus

ASJC Scopus subject areas

  • Hepatology

Cite this

Complications, symptoms, quality of life and pregnancy in cholestatic liver disease. / Zakharia, Kais; Tabibian, Anilga; Lindor, Keith; Tabibian, James H.

In: Liver International, Vol. 38, No. 3, 01.03.2018, p. 399-411.

Research output: Contribution to journalReview article

Zakharia, Kais ; Tabibian, Anilga ; Lindor, Keith ; Tabibian, James H. / Complications, symptoms, quality of life and pregnancy in cholestatic liver disease. In: Liver International. 2018 ; Vol. 38, No. 3. pp. 399-411.
@article{f2aec93b0e2044a7ad06a3f860f4cde9,
title = "Complications, symptoms, quality of life and pregnancy in cholestatic liver disease",
abstract = "Cholestatic liver diseases (CLDs) encompass a variety of disorders of bile formation and/or flow which generally result in progressive hepatobiliary injury and ultimately end-stage liver disease. Many patients with CLD are diagnosed between the ages of 20-50 years, a particularly productive period of life professionally, biologically and in other respects; it is not surprising, thus, that CLD is often associated with impaired health-related quality of life (HRQOL) and uncertainty regarding implications for and outcomes of pregnancy. Primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) are the most prominent CLDs, both having considerable morbidity and mortality and representing major indications for liver transplantation. These disorders, as a consequence of their complications (eg ascites, hepatic osteodystrophy), associated conditions (eg inflammatory bowel disease) and symptoms (eg pruritus and fatigue), can significantly impair an array of domains of HRQOL. Here we review these impactful clinical aspects of PSC and PBC as well as the topics of fertility and pregnancy.",
keywords = "biliary tract diseases, pharmacotherapy, primary biliary cholangitis, primary sclerosing cholangitis, pruritus",
author = "Kais Zakharia and Anilga Tabibian and Keith Lindor and Tabibian, {James H.}",
year = "2018",
month = "3",
day = "1",
doi = "10.1111/liv.13591",
language = "English (US)",
volume = "38",
pages = "399--411",
journal = "Liver International",
issn = "1478-3223",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Complications, symptoms, quality of life and pregnancy in cholestatic liver disease

AU - Zakharia, Kais

AU - Tabibian, Anilga

AU - Lindor, Keith

AU - Tabibian, James H.

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Cholestatic liver diseases (CLDs) encompass a variety of disorders of bile formation and/or flow which generally result in progressive hepatobiliary injury and ultimately end-stage liver disease. Many patients with CLD are diagnosed between the ages of 20-50 years, a particularly productive period of life professionally, biologically and in other respects; it is not surprising, thus, that CLD is often associated with impaired health-related quality of life (HRQOL) and uncertainty regarding implications for and outcomes of pregnancy. Primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) are the most prominent CLDs, both having considerable morbidity and mortality and representing major indications for liver transplantation. These disorders, as a consequence of their complications (eg ascites, hepatic osteodystrophy), associated conditions (eg inflammatory bowel disease) and symptoms (eg pruritus and fatigue), can significantly impair an array of domains of HRQOL. Here we review these impactful clinical aspects of PSC and PBC as well as the topics of fertility and pregnancy.

AB - Cholestatic liver diseases (CLDs) encompass a variety of disorders of bile formation and/or flow which generally result in progressive hepatobiliary injury and ultimately end-stage liver disease. Many patients with CLD are diagnosed between the ages of 20-50 years, a particularly productive period of life professionally, biologically and in other respects; it is not surprising, thus, that CLD is often associated with impaired health-related quality of life (HRQOL) and uncertainty regarding implications for and outcomes of pregnancy. Primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) are the most prominent CLDs, both having considerable morbidity and mortality and representing major indications for liver transplantation. These disorders, as a consequence of their complications (eg ascites, hepatic osteodystrophy), associated conditions (eg inflammatory bowel disease) and symptoms (eg pruritus and fatigue), can significantly impair an array of domains of HRQOL. Here we review these impactful clinical aspects of PSC and PBC as well as the topics of fertility and pregnancy.

KW - biliary tract diseases

KW - pharmacotherapy

KW - primary biliary cholangitis

KW - primary sclerosing cholangitis

KW - pruritus

UR - http://www.scopus.com/inward/record.url?scp=85042356343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042356343&partnerID=8YFLogxK

U2 - 10.1111/liv.13591

DO - 10.1111/liv.13591

M3 - Review article

C2 - 28921801

AN - SCOPUS:85042356343

VL - 38

SP - 399

EP - 411

JO - Liver International

JF - Liver International

SN - 1478-3223

IS - 3

ER -